2nd Quarter - Report — ELI LILLY AND COMPANY for ELI LILLY AND COMPANY (2019)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

ELI LILLY AND COMPANY

Client

ELI LILLY AND COMPANY

Income

—

Expenses

$2,330,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
2nd Quarter - Report (this page)	Jul 16, 2019	$2,330,000	Replaced
2nd Quarter - Amendment	Jul 17, 2019	$2,330,000	Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Hospital discounts; 340B program

Lobbyist	Covered position, as disclosed
SARAH KYLE	—

Contacted: Office of Management & Budget (OMB); SENATE; State, Dept of (DOS); Justice, Dept of (DOJ); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Health Issues HCR

Patient protection; Drug shortages; Drug pricing and value; Dormant Therapies Act; PDUFA; BSUFA

Lobbyist	Covered position, as disclosed
SARAH KYLE	—
SHAWN O'NEAIL New	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—

Contacted: Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Homeland Security, Dept of (DHS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Commerce, Dept of (DOC)

Copyright/Patent/Trademark CPT

Hatch Waxman Integrity Act

Lobbyist	Covered position, as disclosed
SARAH KYLE	—
JESSE PRICE	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—

Contacted: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Homeland Security, Dept of (DHS); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE

Trade (domestic/foreign) TRD

Issues related to intellectual property protection and market acccess within current trade negotiations; Turkey IPR and Pricing; Canada IP; USMCA Passage; Saudi Arabia; Thailand OCPA; Malaysia Compulsory Licenses; Special 301; Trade talks - US-Japan, US-China, US-EU, and US-UK

Lobbyist	Covered position, as disclosed
PAUL BURKHEAD	—
HARRISON C COOK	—
CATHERINE HINCKLEY	—
SARAH KYLE	—
SHAWN O'NEAIL New	—
JESSE PRICE	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—

Contacted: Justice, Dept of (DOJ); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); SENATE; Homeland Security, Dept of (DHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act

Lobbyist	Covered position, as disclosed
JESSE PRICE	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC); SENATE; Office of Management & Budget (OMB)

Medicare/Medicaid MMM

Intellectual property; Dormant Therapies Act; 340B Program; PPACA

Lobbyist	Covered position, as disclosed
SARAH KYLE	—
SHAWN O'NEAIL New	—
JESSE PRICE	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Justice, Dept of (DOJ); Homeland Security, Dept of (DHS); Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; Office of Management & Budget (OMB)

Consumer Issues/Safety/Products CSP

Anti-counterfeiting; Patient safety; Drug pedigree; Serialization and traceability issues; Drug Quality and Security Act; Protecting consumers from illegal online drug sales; Promoting public-private partnerships; UN High Level Panel on Access to Medicines (NHHLP) and other multi-lateral threats to IP and the biopharmaceutical industry; Drug importation

Lobbyist	Covered position, as disclosed
SARAH KYLE	—
SHAWN O'NEAIL New	—
JESSE PRICE	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Commerce, Dept of (DOC); SENATE; Justice, Dept of (DOJ); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.